Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 11, 2014 - Issue 1
Submit an article Journal homepage
1,315
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Biochemical Efficacy and Safety of a New, Ready-to-Use, Liquid Alpha-1-Proteinase Inhibitor, GLASSIA (Alpha1-Proteinase Inhibitor (Human), Intravenous)

Robert A. SandhausNational Jewish Health, Denver, CO, USACorrespondence[email protected]
,
James StocksThe University of Texas Health Science Center, Tyler, TX, USA
,
Farshid N. RouhaniUniversity of Florida, Gainesville, FL, USA
,
Mark BrantlyUniversity of Florida, Gainesville, FL, USA
&
Pnina StraussKamada, Ltd., Nes Ziona, Israel
Pages 17-25 | Published online: 03 Jul 2013

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Kenneth R Chapman, Joanna Chorostowska-Wynimko, A Rembert Koczulla, Ilaria Ferrarotti & Noel G McElvaney. (2018) Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 419-432.
Read now
Ross G Edgar, Mitesh Patel, Susan Bayliss, Diana Crossley, Elizabeth Sapey & Alice M Turner. (2017) Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1295-1308.
Read now
Fernando O Martinez & Siamon Gordon. (2015) The evolution of our understanding of macrophages and translation of findings toward the clinic. Expert Review of Clinical Immunology 11:1, pages 5-13.
Read now
Oliver J McElvaney, Abdelhaleem M E Bella & Noel G McElvaney. (2015) α-1 antitrypsin deficiency: current and future treatment options. Expert Opinion on Orphan Drugs 3:1, pages 5-14.
Read now
Leock Y Ngo, Adam Haeberle, Jacqueline Dyck-Jones, David Gelmont & Leman Yel. (2014) Safety and tolerability of an intravenously administered alpha1-proteinase inhibitor at an increased infusion rate: a novel, randomized, placebo-masked, infusion rate-controlled, crossover study in healthy adults. Open Access Journal of Clinical Trials 6, pages 55-61.
Read now

Articles from other publishers (10)

Zhaoyang Li, Ryan M. Franke, Denise N. Morris & Leman Yel. (2022) Pharmacokinetics and Biochemical Efficacy of an α1-Proteinase Inhibitor (Aralast NP) in α1-Antitrypsin Deficiency: a Cross-Product Retrospective Comparability Analysis. Pulmonary Therapy 8:3, pages 311-326.
Crossref
Zhaoyang Li, Ryan M. Franke, Denise Morris & Leman Yel. (2022) Comparative biochemical efficacy analysis of an alpha1-proteinase inhibitor (Glassia®) in patients with alpha-1 antitrypsin deficiency. Pulmonary Pharmacology & Therapeutics 73-74, pages 102124.
Crossref
Martina Oriano, Francesco Amati, Andrea Gramegna, Anthony De Soyza, Marco Mantero, Oriol Sibila, Sanjay H. Chotirmall, Antonio Voza, Paola Marchisio, Francesco Blasi & Stefano Aliberti. (2021) Protease–Antiprotease Imbalance in Bronchiectasis. International Journal of Molecular Sciences 22:11, pages 5996.
Crossref
Paul Ellis, Asger Dirksen & Alice M. Turner. 2019. α 1 -Antitrypsin Deficiency . α 1 -Antitrypsin Deficiency 78 92 .
Diana Crossley, Robert Stockley & Elizabeth Sapey. (2019) Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?. Drugs & Aging 36:9, pages 823-840.
Crossref
Bari, Ferrarotti, Di Silvestre, Grisoli, Barzon, Balderacchi, Torre, Rossi, Mauri, Corsico & Perteghella. (2019) Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration. Cells 8:9, pages 965.
Crossref
Article Editorial. (2018) Diagnosis and treatment of pulmonarydisease in α1-antitrypsin deficiency: a statement of European Respiratory Society. Russian Pulmonology 28:3, pages 273-295.
Crossref
Marc Miravitlles, Asger Dirksen, Ilaria Ferrarotti, Vladimir Koblizek, Peter Lange, Ravi Mahadeva, Noel G. McElvaney, David Parr, Eeva Piitulainen, Nicolas Roche, Jan Stolk, Gabriel Thabut, Alice Turner, Claus Vogelmeier & Robert A. Stockley. (2017) European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α 1 -antitrypsin deficiency . European Respiratory Journal 50:5, pages 1700610.
Crossref
Susan Sorrells, Sandra Camprubi, Rhonda Griffin, Junliang Chen & Jaume Ayguasanosa. (2015) SPARTA clinical trial design: Exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency. Respiratory Medicine 109:4, pages 490-499.
Crossref
Gabriella Fleixo-Lima, Hilla Ventura, Michal Medini, Liliana Bar, Pnina Strauss & Eli C. Lewis. (2014) Mechanistic Evidence in Support of Alpha1-Antitrypsin as a Therapeutic Approach for Type 1 Diabetes. Journal of Diabetes Science and Technology 8:6, pages 1193-1203.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.